In This Episode

Join David Goldsmith as he welcomes Ken Sabin, Chief Science Officer at Redwire, to explore the transformative potential of science in space. With over 20 years in the pharmaceutical industry, Ken shares his insights on how space exploration can lead to groundbreaking advancements in medicine and technology. Key moments include discussions on the unique benefits of microgravity for crystal growth and tissue engineering, as well as the importance of collaboration between private companies and governmental agencies. The conversation takes unexpected turns as they delve into the challenges faced by organizations like Astrobotic and the broader implications for humanity's future in space.

Ken emphasizes that the ultimate goal of space science is to improve life on Earth through innovative solutions derived from extraterrestrial research. As they discuss the evolution of space exploration, listeners gain a deeper understanding of how these efforts can bridge gaps between technology and human welfare.

Episode Outlines

Biography of the Guest

Ken Sabin is the Chief Science Officer at Redwire, where he leads innovative projects focused on advancing science and technology in space. With a PhD in chemistry and over two decades of experience in the pharmaceutical industry, Ken has worked with prominent firms such as Eli Lilly. His current projects include protein crystal growth and biofabrication facilities aboard the International Space Station. Ken is passionate about leveraging space research to create solutions that benefit humanity on Earth, making him a vital voice in discussions about the future of science and exploration.